News Medical on MSN

ASTRO: New Prostate Cancer Therapies, SBRT, 5DCT Advances

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

AIIMS radiologist warns ‘men should get prostate cancer screening at 40 if they have family history on father’s side’

AIIMS radiologist stresses importance of early prostate cancer screening, starting at age 50, or earlier for those with risk ...
Oncology Nurse Advisor

Biparametric MRI Noninferior for Diagnosing Prostate Cancer

Clinically significant cancer was detected in 29.2 versus 29.6 percent of men with biparametric and multiparametric MRI.

New therapy delays progression of recurrent prostate cancer

Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...

Prostate cancer stages explained by doctors — what each one really means and key info men should know

Prostate cancer stages explain how far cancer has spread. Stage 1 and 2 stay in the prostate and are highly treatable. Stage ...
The Malaysian Reserve

Plenary Presentation at The ASTRO Meeting by TGH Cancer Institute Member Dr. Rodney Ellis Demonstrated That Short-course Radiation Improves Quality of Life for Men with ...

Phase III trial presented at ASTRO in San Francisco finds five-treatment regimen poised to become new standard of care. SAN FRANCISCO, Sept. 29, 2025 ...
UroToday

ASTRO 2025: Conventional vs. Hypofractionated, Radiotherapy for High-Risk Prostate Cancer: 10-Year Outcomes of the Randomized, Non-Inferiority, Phase 3 PCS5 Trial

The PCS5 trial is a Canadian multicenter, open-label, phase III randomized trial that included men with histologically proven, clinically localized prostate cancer with ≥1 high-risk feature (s) ...